BioSpace News Archive

Ampio Pharmaceuticals, Inc., a clinical trial stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options, today announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of common stock in an underwritten public offering.

Johnson & Johnson announced today the appointment of Chris DelOrefice to Vice President of Investor Relations for Johnson & Johnson, effective August 13, 2018.

Acquisition strengthens Nelson Labs’ outsourced testing capabilities to better serve the pharmaceutical and medical device industries

Xcertia is pleased to announce the addition of four new directors and two ex officio board members to Xcertia’s leadership.

New Service Capability Adds Value for Existing Attis Healthcare Customers

Altasciences is pleased to announce that, for a fourth consecutive year, CEO Chris Perkin has been honored as one of the 100 Most Inspiring Leaders in the Life Sciences Industry by PharmaVOICE magazine.

Dr. Jay Kang, clinical director of Zen Care Physical Medicine has introduced Regenerative Stem Cell Therapy at his Irvine, CA office to help his patients overcome certain debilitating injuries.

Bio-Techne has introduced a new range of Tocris Bioscience-branded stem cell research compounds produced to cGMP standards, which are suitable for use as ancillary materials in the development of stem cell therapies.

EdiGene Inc.today announced the successful completion of approximately $15 Million in a Series pre-B financing.

WellCare Health Plans, Inc. announced that it priced an offering of $750 million aggregate principal amount of 5.375% senior notes due 2026 (the “notes”).